I can vividly recall an incident that occurred inside the infusion room one day last November. It was the third hour of a four-hour drip…
Myeloma
The first patient has been dosed in a Phase 2 trial testing an all-oral, triple-combination treatment that includes Cellcentric’s investigational therapy inobrodib in people…
A few weeks ago, I wrote about the annual challenge I face during the season of Lent: the temptation of Thin Mints. The Thin…
Recently, I’ve observed a new type of quietness between my mum and me. It is not the usual silence that arises after a myeloma…
A European Medicines Agency (EMA) panel has recommended approval of a subcutaneous (under-the-skin) version of Sarclisa (isatuximab), an approved myeloma treatment sold by Sanofi. The…
I just had my quarterly tuneup and oil change — not for my car, though. For me. Just like a car needs regular maintenance, a…
I had asked my mum a simple question about her lunch, but what came back at me made me question why I had ever decided…
Most doctors who treat multiple myeloma expect that CAR T-cell therapies will soon became the standard first-line treatment, according to new research from…
Have you ever heard something like this after telling someone you have multiple myeloma? “Oh, my uncle had that! It was on his nose!”…
As a caregiver, I can recall some moments when the kindest thing I could have done felt brutal. Sometimes, when I reflect on the…
Recent Posts
- Infection risk shifts over time with both CAR T and bispecific antibody therapy
- Building the quiet architecture of a caregiving day
- New CAR T-cell therapy shows promise in tough myeloma cases
- CAR T-cell therapy before surgery boosts glioblastoma control in mice
- Gynecologic Cancer Awareness Month urges education, action, and support